When: Tuesday, September 29th, 5:30pm – 7:30pm (speaker at 6:15pm)
Where: Madison Club, Madison WI
Link: Conversation with Kevin Conroy – former Chairman and CEO of Exact Sciences
Tickets discounted $10 for students
Interview and Discussion with Kevin Conroy, former Chairman and CEO of Exact Sciences.
Conroy served as CEO of Exact Sciences from 2009 to 2026 and Chairman from 2014, transforming the company into one of the world’s leading cancer diagnostics companies. Under his leadership, Exact Sciences developed Cologuard®, the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Today, Cologuard has been used more than 23 million times to screen for colorectal cancer.
In 2019, Exact Sciences acquired Genomic Health, adding Oncotype DX®, which has helped more than two million breast cancer patients make more informed treatment decisions. The company continued to expand its portfolio with Oncodetect® for molecular residual disease testing, Cancerguard™ for blood-based multi-cancer early detection, and Riskguard™ for hereditary cancer risk assessment. Exact Sciences was acquired by Abbott in March 2026.
Prior to Exact Sciences, Conroy led Third Wave Technologies. He currently serves as a director of Abbott and CereVasc, Inc., and as Chairman of the Board of Align Technology. He holds a B.S. in electrical engineering from Michigan State University and a J.D. from the University of Michigan.
Join us for an evening of conversation and connection as Kevin shares his leadership experiences, lessons learned, and perspective on building and leading a transformative organization.
5:15 PM: Registration
5:30 PM: Networking Workshop with Susan Thomson of ActionCOACH (Optional)
6 PM: Registration Continues
6:10 PM: Introductions
6:15 PM: Interview with Kevin Conroy – Moderated by Mark O’Connell
7 PM: Audience Q&A
7:15 PM: Wrap-up with Kevin Conroy; Networking and Hors d’oeuvres Begin